While short-term DOAC was not significantly better than dual antiplatelet therapy (DAPT) at preventing device-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback